Oruka Therapeutics
ORKA
15 hedge funds and large institutions have $863K invested in Oruka Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
24% more capital invested
Capital invested by funds: $694K → $863K (+$169K)
15% more funds holding
Funds holding: 13 → 15 (+2)
0.01% less ownership
Funds ownership: 0.07% → 0.06% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$34.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$33.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.9K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$27K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$5.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$28K |
| 2 |
GWMIA
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
|
-$444 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $337K | +$34.1K | +384 | +10% |
|
|
TCM
2
Tekla Capital Management
Boston,
Massachusetts
| $303K | – | – | – |
|
|
3
Acadian Asset Management
Boston,
Massachusetts
| $82K | +$27K | +304 | +43% |
|
|
ACP
4
Aveo Capital Partners
Englewood,
Colorado
| $35K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $31K | +$33.7K | +379 | New |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $27K | +$29.9K | +337 | New |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $19K | – | – | – |
|
8
Geode Capital Management
Boston,
Massachusetts
| $18K | – | – | – |
|
9
Northern Trust
Chicago,
Illinois
| $5K | – | – | – |
|
|
TSS
10
Two Sigma Securities
New York
| $5K | +$5.15K | +58 | New |
|
11
Morgan Stanley
New York
| $1K | – | – | – |
|
|
PAM
12
Panagora Asset Management
Boston,
Massachusetts
| – | -$28K | -386 | Closed |
|
|
GWMIA
13
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
| – | -$444 | -5 | -71% |
|
ORKA Hedge Fund Activity: Q1 2019 in Review
15 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Oruka Therapeutics (ORKA) for Q1 2019, worth a combined $863K — up 24% from $694K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ORKA positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $34.1K. The largest seller was Panagora Asset Management, exiting entirely with an estimated $28K sold.
- 15 institutional investors held Oruka Therapeutics (ORKA) as of Q1 2019, up from 13 in Q4 2018.
- Funds reported $863K of Oruka Therapeutics stock for Q1 2019, up 24% quarter-over-quarter.
- 3 funds opened new Oruka Therapeutics positions in Q1 2019 and 1 closed out, a net change of +2 holders.
- The largest Oruka Therapeutics buyer in Q1 2019 was Renaissance Technologies, an estimated $34.1K added.
- The largest Oruka Therapeutics seller in Q1 2019 was Panagora Asset Management, an estimated $28K sold.
Based on aggregated 13F filings for Q1 2019.